MMP9 and CCL18 associate with chronic urticaria while type I, IV, and VI collagens change with omalizumab treatment.
Ewa A BartkoMaiken MellergaardSolveig S GroenSigne Holm NielsenJesper ElberlingAase HandbergLars K PoulsenLars H BlomBettina M JensenPublished in: Allergy (2024)